Work

Correction to: Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment

Year: 2023

Type: erratum

Source: Clinical Pharmacokinetics

DOI: 10.1007/s40262-023-01236-4

Authors: Mikkel Askjær Agersnap, Kim Sonne, Kim Mark Knudsen, Wladyslaw Sulowicz

Institution: Zealand Pharma (Denmark)

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,390

OpenAlex ID: W4324017686

Cites:

Cited by: 1

Related to: 10